Question 1

What are the potential side effects of LP-108?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase I Study of LP-108 in Patients With Relapsed or Refractory B-cell Lymphoma clinical trial (NCT04356846). Contact the study team or your healthcare provider for specific answers.

Question 2

How does this treatment compare to my current options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase I Study of LP-108 in Patients With Relapsed or Refractory B-cell Lymphoma clinical trial (NCT04356846). Contact the study team or your healthcare provider for specific answers.

Question 3

What will the treatment process look like, including visits and tests?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase I Study of LP-108 in Patients With Relapsed or Refractory B-cell Lymphoma clinical trial (NCT04356846). Contact the study team or your healthcare provider for specific answers.

Question 4

Are there any specific eligibility criteria I should be aware of?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase I Study of LP-108 in Patients With Relapsed or Refractory B-cell Lymphoma clinical trial (NCT04356846). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience side effects during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase I Study of LP-108 in Patients With Relapsed or Refractory B-cell Lymphoma clinical trial (NCT04356846). Contact the study team or your healthcare provider for specific answers.

Question 6

How will my health be monitored throughout the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase I Study of LP-108 in Patients With Relapsed or Refractory B-cell Lymphoma clinical trial (NCT04356846). Contact the study team or your healthcare provider for specific answers.

What this study is about